Zevia PBC director David J. Lee proposes $231K sale

The notice also lists five restricted-stock vesting acquisitions, dated from June 2023 through June 2026.

Available on EDGAR 11/09/2026 - 04:31 PM EST Accepted by SEC EDGAR 11/09/2026 - 04:30 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Zevia PBC director David J. Lee reported a proposed sale of 179,589 common shares, with an aggregate market value of $231,041.25 and an approximate sale date of November 9, 2026. Morgan Stanley Smith Barney LLC is listed as the broker.

The notice lists five restricted-stock vesting acquisitions: 34,722 shares on June 10, 2026; 118,384 shares and 71 shares on June 12, 2025; 4,155 shares on June 15, 2024; and 22,257 shares on June 9, 2023.

Key Figures

Shares reported for sale: 179,589 common shares Aggregate market value: $231,041.25 Restricted stock acquired: 34,722 shares +4 more

7 metrics

Shares reported for sale 179,589 common shares David J. Lee's notice

Aggregate market value $231,041.25 Shares reported for sale

Restricted stock acquired 34,722 shares Vesting on June 10, 2026

Restricted stock acquired 118,384 shares Vesting on June 12, 2025

Restricted stock acquired 71 shares Vesting on June 12, 2025

Restricted stock acquired 4,155 shares Vesting on June 15, 2024

Restricted stock acquired 22,257 shares Vesting on June 9, 2023

Key Terms

Restricted Stock Vesting Under a Registered Plan, Aggregate Market Value, Approximate Date of Sale

3 terms

Restricted Stock Vesting Under a Registered Plan financial

"Restricted Stock Vesting Under a Registered Plan"

Aggregate Market Value financial

"Aggregate Market Value"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

Approximate Date of Sale financial

"Approximate Date of Sale"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ZVIA shares did David J. Lee report for sale?

David J. Lee reported 179,589 common shares for sale, with an aggregate market value of $231,041.25. Morgan Stanley Smith Barney LLC is listed as the broker.

When is the ZVIA share sale by David J. Lee expected?

The notice lists November 9, 2026 as the approximate date of sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001605182
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ZEVIA PBC
SEC File Number	001-40630
Address of Issuer	15821 Ventura Blvd. Suite 145 Encino CALIFORNIA 91436
Phone	424-343-2654
Name of Person for Whose Account the Securities are To Be Sold	DAVID J LEE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	179589	231041.25	72180311	11/09/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/10/2026	Restricted Stock Vesting Under a Registered Plan	Issuer			34722	06/10/2026	Compensation
Common	06/12/2025	Restricted Stock Vesting Under a Registered Plan	Issuer			118384	06/12/2025	Compensation
Common	06/12/2025	Restricted Stock Vesting Under a Registered Plan	Issuer			71	06/12/2025	Compensation
Common	06/15/2024	Restricted Stock Vesting Under a Registered Plan	Issuer			4155	06/15/2024	Compensation
Common	06/09/2023	Restricted Stock Vesting Under a Registered Plan	Issuer			22257	06/09/2023	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	11/09/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ David J Lee
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)